chrisvoncsefalvay/vaers-outcomes huggingface dataset:
bone aches (back/ribs/arms); brain fog; congestion; fatigue; Mainly muscle aches (back/ribs/arms).; headache; Interchange of vaccine products; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 24-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 09Oct2023 at 11:30 as dose 1, single (Lot number: HF9275) at the age of 24 years intramuscular, in left arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 09Oct2023 as dose number unknown, single (Batch/Lot number: unknown), in left arm for influenza immunisation. The patient's relevant medical history included: "COVID-19" (unspecified if ongoing), notes: If covid prior vaccination: Yes. The patient's concomitant medications were not reported. Vaccination history included: johnson & johnson (Dose Number: 1, Batch No: 041A21A, Site: Arm Left, Time: 12:00 PM, ROA: Intramuscular), administration date: 01Apr2021, when the patient was 22-year-old, for COVID-19 immunization; moderna (Dose Number: 2, Batch No: 017F21A, Site: Arm Left, Time: 12:00 PM, ROA: Intramuscular), administration date: 29Oct2021, when the patient was 22-year-old, for COVID-19 immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 09Oct2023 at 11:30, outcome "unknown"; MYALGIA (non-serious) with onset 09Oct2023 at 20:00, outcome "recovered" (Oct2023), described as "Mainly muscle aches (back/ribs/arms)."; BONE PAIN (non-serious) with onset 09Oct2023 at 20:00, outcome "recovered" (Oct2023), described as "bone aches (back/ribs/arms)"; BRAIN FOG (non-serious) with onset 09Oct2023 at 20:00, outcome "recovered" (Oct2023); NASAL CONGESTION (non-serious) with onset 09Oct2023 at 20:00, outcome "recovered" (Oct2023), described as "congestion"; FATIGUE (non-serious) with onset 09Oct2023 at 20:00, outcome "recovered" (Oct2023); HEADACHE (non-serious) with onset 09Oct2023 at 20:00, outcome "recovered" (Oct2023). Therapeutic measures were not taken as a result of bone pain, brain fog, nasal congestion, fatigue, myalgia, headache.  Additional information: Reported that, Mainly muscle and bone aches (back/ribs/arms). Also, headache and brain fog, congestion, and fatigue. The patient had no known allergies.
Reported by Grandmother child had a head to toe rash that developed that evening. No other symptoms reported.
Dose administered from an expired vial; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered from an expired vial) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered from an expired vial). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered from an expired vial) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment drug provided   Reporter did not allow further contact
PATIENT CALLED PHARMACY A DAY AFTER SHE RECEIVED HER 2ND DOSE OF PFIZER COVID  VACCINE.  PATIENT STATED THAT SHE HAS A LUMP NEAR HER NECK/CLAVICLE BONE ABOUT A QUARTER SIZE AND IT HURTS WHEN SHE MOVED HER ARM.
This spontaneous report as received from a healthcare worker refers to a 6 unspecified patients of unknown age. On an unknown date, the patients were vaccinated with ROTATEQ (dosage information unknown). No concomitant medication was reported. The patients were vaccinated with improperly stored ROTATEQ which were exposed to 48 degree Fahrenheit for 35 minutes. No adverse effects were reported. A product quality complaint (PQC) was not involved. Additional information has been requested.
Pt received also PNEUMOVAX 23 N012127/01/2019 in the right arm at her request. Pt reported redness, soreness, swelling, and skin feeling hot.
One week after, developed some dizziness that progressed to sever dizziness 9 days after vaccine. Similar to vestibular migraine symptoms. Was unable to get out of bed on day 9. 14 days post vaccine, still experiencing moderate vertigo
16FEB91 pt vax w/ hepta B; 17FEB exp fever & chills.  No tx.
Mom reports whitish discoloration starting around injection site along with pain, itch and swelling - 10/18/17. On 10/19/17 symptoms continued along with developing redness to site and warmth.  10 x 12 cm redness measured in office on 10/19/17.
About a week after my first dose, the injection site had a slight rash. It was itchy and pink, like a mosquito bite that had been scratched too much. It showed up the same morning as my left armpit lymph node was swelling and slightly tender, which was my only noticeable immune response to the vaccine. Both were pretty much gone the next day. I had my 2nd dose today and they told me to write in my adverse reaction of the rash.
Patient developed itchy rash on injection site 7 days after receiving the vaccine. Patient self treated with Benadryl 25mg at bedtime and Allegra 60mg in the morning, patient also applied some clobetasol oint. On 1/11/21, the rash is not visible but patient still can feel some itchiness.
14yo experienced redness (2'x3' oval shape), pain & swelling @ inject site w/in 24hrs p/immun; Tx APAP & cold compresses @ inject site, child has since recovered w/no sequelae;
Rash; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 42years) as unknown, single for COVID-19 immunization. Medical history and concomitant medications were not reported. On 12May2021 the patient experienced rash. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt exp brief pallor & limpness about 24-36 hrs p/vax; no fever;
On 3/15/18 patient received three vaccines. ENGERIX B (NDC 58160-0821-43) in her left arm. HAVRIX (NDC 58160-0826-43) and SHINGRIX (NDC 58160-0828-03) in her right arm (HAVRIX lower, SHINGRIX upper). Patient called today complaining of redness and swelling in her right arm. She said that it also feels warm to touch. She said where the redness located is more of her inward arm closer to her armpit, not in the exact spot where she got the shots at. But after the shots it was sore/hurting in the area that is now red, so she believes the redness is because of the shots. I told her that because of the warmth and swelling there, there is a chance it could be infected and she should visit her doctor in the case that it is infected so she could get an antibiotic. She said she is out of town so will be unable to go to her doctor. I recommended an urgent care.
patient fainted and had a vasovagal response ... very clammy and sweaty but ended up being fine after several minutes
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Apr2021 as dose 1, single (Lot number: EW0150), in left arm, on 30Apr2021 as dose 2, single (Lot number: EW0169), in left arm, on 21Nov2021 as dose 3 (booster), single (Lot number: FH8030), in left arm and on 17Jul2022 as dose 4 (booster), single (Lot number: FJ4991) at the age of 51 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Bmi >40" (unspecified if ongoing), notes: Bmi >40; "Early arthritis" (unspecified if ongoing); "Cold/exercise induced asthma" (unspecified if ongoing); "Cold/exercise induced asthma" (unspecified if ongoing); "Minor heart murmur" (unspecified if ongoing); "Surgical plates/screws in left radius" (unspecified if ongoing), notes: surgical plates/screws in left radius; "Bivalves allergy" (unspecified if ongoing), notes: Bivalves allergy. The patient's concomitant medications were not reported. Past drug history included: Amoxicillin, reaction(s): "Allergy"; Marijuana, reaction(s): "Allergy"; Gin, reaction(s): "Allergy"; Juniper, reaction(s): "Allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures, Paxlovid from 02Dec2022, were taken as a result of vaccination failure, covid-19.
Severe menstruation cramping, heavy menstruation spotting/bleeding. Symptoms started one day after receiving vaccine with cramping. The next day followed by cramping and breakthrough spotting.  Very regular periods otherwise. Last period was sept 1-4th.
Fatigue; mild soreness at injection side; moderate headache; This is a spontaneous report from a contactable consumer (patient). A 47-year-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Lot number: EL3247, Expiration date was not reported), via an unspecified route of administration on 26Jan2021 13:00 left arm as single dose for covid-19 immunisation. The patient medical history was not reported. Allergies to medications, food, or other products reported as no. Concomitant medications included sertraline hydrochloride (ZOLOFT), vitamins nos (MULTIVITAMINUM), desogestrel, ethinylestradiol (VOLNEA) and doxycycline all are taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced mild soreness at injection side, moderate headache, fatigue on 27Jan2021. As per the reporter seriousness criteria reported as non-serious. Patient did not received treatment for the adverse events. The outcome of the events was recovering.
Pt recv vax on 10/30/98; 30 min later pt exp 3x5 in red, hot, tender, hard area at vax site; tx=warm, moist packs & Ibuprofen x6 day
(L) arm red, swollen hot to touch approx 4" x 5"; received 4 vaccines in same arm. Started on Orapred, Zyrtec, cool compresses
This was patients "booster dose of pfizer" Patient reports about 24 hour fever with persistent wheezing for 3 days and dry cough.
Patient was asked at drop-off which dose she is wanting to receive today. Patient responded with wanting to receive her 2nd dose of Moderna. At check-in, patient neglected to mention she already received 1st dose of J&J. Patient also did not have an immunization card for us to verify the 1st dose. Patient confirmed with us multiple times she is receiving her 2nd dose of Moderna today. And then after administration of 0.5 mL, the patient mentioned she received J&J in another place over 2 months ago. Patient received 0.5 mL of Moderna instead of the 0.25 mL booster dose as she should have received.
Information has been received from a father concerning his 31 month old daughter with no medical history who on 05/20/2002 was vaccinated subcutaneously with a dose of varicella virus vaccine live.  There was no concomitant therapy.  The father reported that, two weeks during Christmas, in December 2003, his daughter developed breakthrough chickenpox.  It was unknown if medical attention was sought and no laboratory/diagnostic testing was performed.  Subsequently, the patient recovered from the breakthrough chickenpox.  No further information is available.
Immediately felt dizzy, light headed and heart palpitations   Today the area of the injection is red, swollen, hot to touch and itchy.  Have been very tired with chills all day
tired ever since second dose of vaccine/it's in a way that patient's never been tired before; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired ever since second dose of vaccine/it's in a way that patient's never been tired before) in a female patient of an unknown age who received mRNA-1273 for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced FATIGUE (tired ever since second dose of vaccine/it's in a way that patient's never been tired before). At the time of the report, FATIGUE (tired ever since second dose of vaccine/it's in a way that patient's never been tired before) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medication details was reported. No treatment medication details was reported.
Hospitalized (10.31.21 - still hospitalized / admitted);  COVID-19 positive (10.31.21);  fully vaccinated  CHIEF COMPLAINT:  Acute respiratory failure due to COVID-19 (HCC) HISTORY OF PRESENT ILLNESS: Patient is a 91 y.o. male who presents today with shortness of breath, fatigue, fever and cough for the past few days. PMH of mod-severe COPD (not on O2), venous insufficiency with chronic left ankle ulcer, dysphagia, s/p RLL resection d/t aspirating gold crown, anemia of CKD. He received a Covid booster and flu vaccine 4 days ago, s/s s/s started the next couple days.  In the ED, he was initially afebrile, then temp 100F, non tachycardic (on Lopressor), BP normal. CXR without acute airspace disease; however hypoxic to 88% at rest on multiple trials with ED provider. He did test (+) for Covid. He requires admission for treatment of acute respiratory failure in setting of COPD.  At time of my exam, he is resting in bed, appears tired with mild increased work of breathing, but alert and oriented. Daughter, who is a nutritionist, is at bedside and assists with hx. He's not having other concerns besides the fatigue and SHOB. At baseline, he is independent at an independent living facility. He does have chronic anemia of CKD, gets somewhat regular Fe infusions as well as Retacrit. He had a stroke in the past, has residual dysphagia and often coughs/chokes while eating. He's had venous insufficiency since he was a teen, and has wraps on his legs all the time; follows with general surgery for OP management of an ulcer on left ankle.  He is a beloved member of the volunteer team at this hospital. * Acute respiratory failure due to COVID-19 (HCC) Assessment & Plan -S/P vaccine x2, received booster and influenza vaccine 4 days ago -Fever/cough and fatigue/SHOB for the past 2-3 days, tested (+) today -CXR no acute disease -Needing 2L O2 to maintain sats -Daily inflammatory labs, check viral film array -Remdesivir, decadron, BID lovenox, guaifenesin, duonebs q4 -Treat for CAP, check blood cultures  Progress Note from 11.4.21:  SUBJECTIVE:  Patient is on unresponsive.  Family made a decision yesterday they want to convert him to comfort care only.  I discontinued all medicines.  Discontinue the IVs.  Apparently he has not been doing well for the past 6 months or so also and their minds he has been declining dramatically. Progress Note from 11.5.21:  SUBJECTIVE:  Patient is unresponsive.  He is having still lot of agitation discontinue the Haldol switch him over to Ativan.  He is a do not resuscitate comfort care
Inconsolable crying beginning 7:30PM day of immunizations. Continued intermittently through next day. Treatment with Tylenol, Motrin, Benadryl and comfort measures.
Inappropriate schedule of product administration; Stated she had a very painful night; Is running a fever of 102; She's got a dropping headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Nov-2021 and was forwarded to Moderna on 23-Nov-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Stated she had a very painful night), PYREXIA (Is running a fever of 102), HEADACHE (She's got a dropping headache) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of product administration) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034F21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Flu shot (Caller also stated that on 19 November 2021 she received a flu shot in her left arm.) on 19-Nov-2021. Past adverse reactions to the above products included No adverse reaction with Flu shot.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced MYALGIA (Stated she had a very painful night), PYREXIA (Is running a fever of 102) and HEADACHE (She's got a dropping headache). On 22-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of product administration). On 22-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of product administration) had resolved. At the time of the report, MYALGIA (Stated she had a very painful night), PYREXIA (Is running a fever of 102) and HEADACHE (She's got a dropping headache) outcome was unknown.      First dose of Johnson and Johnson received on 8April2021, Lot: 203A21A.  Patient received the booster dose yesterday on 22Nov2021 about noon, and stated she had a very painful night and is running a fever of 102, and she's got a dropping headache.  No relevant concomitant medications was reported. Treatment information was not provided.  Company Comment : This is a spontaneous case concerning a 75-year-old female patient with no relevant medical history, who experienced non serious, expected events of myalgia, headache and pyrexia. The events occurred on an unknown date after the third dose of mRNA-1273 vaccine. Patient received first dose of Johnson and Johnson COVID 19 vaccine on 8- April- 2021. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 75-year-old female patient with no relevant medical history, who experienced non serious, expected events of myalgia, headache and pyrexia. The events occurred on an unknown date after the third dose of mRNA-1273 vaccine. Patient received first dose of Johnson and Johnson COVID 19 vaccine on 8- April- 2021. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
received first dose of Shingrix 18Dec2021 and did not receive second dose until 18May 2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 18-DEC-2021).   On 18-MAY-2023, the patient received the 2nd dose of Shingrix. On 18-MAY-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: received first dose of Shingrix 18Dec2021 and did not receive second dose until 18May 2023). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 18-JUL-2023 At the time of reporting, the pharmacist did not had the dosing lot numbers. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. Reporter was a floater, so might have to follow-up with different staff member. The patient received 2nd dose of Shingrix later than recommended interval, which led to lengthening of vaccination schedule.
Hives developed on the injection arm and spread across her chest; intense heart palpitations; weakness/dizziness; weakness/dizziness; This is a spontaneous report from a contactable Nurse (patient).   A 29-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at Left arm on 07Jan2021 13:00 at SINGLE DOSE for COVID 19 vaccination. The patient was not pregnant. Medical history included Shellfish allergy. There were no concomitant medications. Historical vaccine included first dose of bnt162b2 on 17Dec2020 07:00 AM at left arm for COVID 19 vaccination. On 07Jan2021, hives developed on the injection arm and spread across her chest within 5 minutes of receiving the vaccine, along with intense heart palpitations and weakness/dizziness. Resolved spontaneously after 10 minutes without any use of epinephrine or other medications. Oral diphenhydramine was taken afterwards. Treatment drug oral diphenhydramine received for events. The outcome of the events was recovered in Jan2021. No covid prior vaccination, no covid test post vaccination. Information on the lot/batch number has been requested.
Information has been received from a registered nurse concerning a 12 month old white male who on 03/02/01, was vaccinated with the 1st dose of MMR, subcutaneously in the left lateral thigh. It was noted at the time of vaccination, that the patient had no illnesses, allergies, birth defects, or medical conditions. On 03/05/01, the patient presented to the office with a fever of 103 - 104 for 3 days. The nurse reported has reported that the patient has also been seen in the ER and was found to have a right ear infection, nasal drainage, and a fever (Other Medical Events). The patient was treated with antibiotics and a decongestant. On 03/12/01, the patient returned to the office with a rash (Other Medical Event). The nurse reported that the patient recovered from his experiences. No further info is available.
Pt received the vaccine on 1/30/21  Pt reported symptoms of left armpit pain to wife on 2/7/21, went to work 4 am 2/8/21 and found face down, dead at work later that morning. Pt worked at a pet store, per wife he did complete his tasks and generally comes home by 7:30 am. Wife called when pt did not come back home and he was found dead.